Gastroenteropancreatico Tumors
1 clinical trials · Condition
◉ Watch Gastroenteropancreatico Tumors
| Record | Firm | Date |
|---|---|---|
| Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) (NCT04086485) | National Cancer Institute (NCI) | 2022-10-03 |
Track Gastroenteropancreatico Tumors automatically
Every clearance here is in the API, with alerts when new ones post.